APVO Aptevo Therapeutics
- 0.706
- +0.026+3.84%
- 0.700
- -0.006-0.86%
Aptevo Therapeutics News
US Equity Markets Close Mixed After March Producer Price Inflation Data
US equity markets closed mixed Thursday following the wholesale producer price inflation data for March. * The US producer price index increased 2.1% year-over-year in March, accelerating from 1.6% in
Why Aptevo Therapeutics Stock Is Cratering
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares are trading lower Thursday after the company priced its $4.6 million public offering.The Details:Aptevo announced the pricing of a public offering of 3,40
Top Midday Decliners
Aptevo Therapeutics (APVO) said it priced a public offering of 3.4 million shares and warrants to purchase up to 6.8 million shares at $1.35 a share and associated common warrant, targeting gross proc
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday's session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9
NKTR, VERU and EGIO Among Mid-day Movers
Dow Dips 100 Points; CarMax Earnings Miss Views
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday. The Dow traded down 0.35% to 38,328.18 while the NASDAQ rose 0.50% to 16,251.71. The S&
Enlivex Therapeutics, Nyxoah SA, China SXT Pharmaceuticals Among Healthcare Movers
Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94.
Aptevo Therapeutics (APVO) Faces Sharp Decline in Premarket Trading
Aptevo Therapeutics Inc. (NASDAQ: APVO) experienced a tumultuous Wednesday as its stock price took a staggering 26% nosedive, plummeting from $3.26 to $2.40. However, the woes for investors didn't end there. In the early premarket hours on Thursday, APVO continued its downward spiral, plunging a further 42% to as low as $1.40. The drastic drop ...
Aptevo Therapeutics Slumps After Discounted Equity Raise
Express News | Aptevo Therapeutics Shares Are Trading Lower After the Company Priced Its $4.6 Million Public Offering
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersEliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday's pre-market session. The market value of their outstanding shares is at $112.2 million. Rallybio (NASDAQ:
Express News | Aptevo Therapeutics Priced Its Public Offering Of 3.4M Shares And Warrants To Purchase Up To 6.8M Shares At $1.35/Share And Associated Common Warrant, With Gross Proceeds Of $4.6M
Top Premarket Decliners
Aptevo Therapeutics (APVO) shares slumped 26% Thursday premarket, extending Wednesday's losses. United Homes Group (UHG) shares retreated 15% following a 2.1% drop in the previous session. SolarBank (
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Rallybio Corporation (NASDAQ:RLYB) rose sharply in today's pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individ
Aptevo Therapeutics, TRACON Pharmaceuticals, Biosig Technologies Among Healthcare Movers
Aptevo Therapeutics Announces Advancements In Clinical Programs And One Preclinical Program
Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now successfully transitioned to a higher dose level, accessing the potential for greater clinical benefit in the ALG.APV-527 clinical trial
Aptevo Therapeutics Provides Pipeline Update
Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now successfully transitioned to a higher dose level, accessing the potential for greater clinical benefit in the ALG.APV-527 clinical trial
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersBiolase (NASDAQ:BIOL) stock rose 20.0% to $0.18 during Thursday's after-market session. The market value of their outstanding shares is at $3.4 million. As per the press release, Q4 earnings ca
Aptevo Therapeutics to Sell Up to 922,059 Shares Together With Up to 1,845,018 Warrants
Aptevo Therapeutics to Sell Up to 922,059 Shares Together With Up to 1,845,018 Warrants
Analysis
Price Target
No Data
